Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 7, 2019; 25(29): 3985-3995
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3985
Figure 4
Figure 4 Pattern diagram of liquid biopsy with serum alanine aminotransferase, bilirubin, and plasma DNA for assessment of hepatocellular injury in hepatitis B patients. Serum alanine aminotransferase levels in patients with severe hepatocellular injury may not be very high and plasma DNA combined with serum bilirubin may be a good complementary biomarker for these patients. ALT: Alanine aminotransferase.